Shaji K. Kumar, MD¹, Thierry Facon, MD^2*, Saad Z. Usmani, MD, MBBS, MBA³, Torben Plesner, MD, DSc⁴, Robert Z. Orlowski, MD, PhD⁵, Cyrille Touzeau^6*, Supratik Basu^7*, Nizar Bahlis, MD⁸, Hartmut Goldschmidt, MD⁹, Michael O'Dwyer, MD¹⁰, Christopher P. Venner, MD¹¹, Katja Weisel, MD^12*, Cyrille Hulin, MD^13*, Lionel Karlin, MD^14*, Meir Preis, MD, PhD¹⁵, Annemiek Broyl, MD, PhD^16*, William Renwick^17*, Markus Hansson, MD^18*, Maria Krevvata, PhD^19*, Jianping Wang^20*, Rian Van Rampelbergh^21*, Jon Ukropec, PhD²², Clarissa M. Uhlar^19*, Rachel Kobos, MD²⁰ and Aurore Perrot, MD, PhD^23*

¹Department of Hematology, Mayo Clinic Rochester, Rochester, MN
²CHU Lille, Service des Maladies du Sang F-59000, Lille, France
³Levine Cancer Institute, Charlotte, NC
⁴Vejle Hospital and University of Southern Denmark, Vejle, Denmark
⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁶Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France
⁷Royal Wolverhampton Hospitals NHS Trust and University, Wolverhampton, United Kingdom
⁸Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
⁹Internal Medicine V and National Center for Tumor Diseases, University Clinic Heidelberg, Heidelberg, Germany
¹⁰NUI, University College Hospital, Galway, Galway, Ireland
¹¹Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
¹²Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹³Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France
¹⁴Department of Hematology, Lyon-Sud Hospital, Pierre-Benite, France
¹⁵Carmel MC, Haifa, Israel
¹⁶Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹⁷Western Health, Sunshine Hospital, Cancer Services, St Albans, Victoria, Australia
¹⁸Department of Hematology, Skåne University Hospital, Lund, Sweden
¹⁹Janssen Research & Development, LLC, Spring House, PA
²⁰Janssen Research & Development, LLC, Raritan, NJ
²¹Janssen Research & Development, Beerse, Belgium
²²Janssen Global Medical Affairs, Horsham, PA
²³CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Jason Valent, MD¹, John Silowsky, RN BSN^2*, Michael R. Kurman, MD³, Eileen Daniel^2*, Janet Jobes^2*, Mark Harnett, MS^4*, Margaret Ziola, MD^2*, Jessica Roviwong^2*, Sherry Fada^1*, Michael Spector, BS^2* and Susan B. Sobolov, PhD^2*

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Caelum Biosciences, Bordentown, NJ
³Michael Kurman Consulting, LLC, Upper Saddle River, NJ
⁴Caelum Biosciences, Stow, MA

Rakesh Popat^1*, Sagar Lonial, MD², Peter M. Voorhees, MD³, Simona Degli Esposti, MD^4*, Ira Gupta, MD^5*, Joanna Opalinska, MD⁵, Sandhya Sapra, PhD^5*, Boris Gorsh, PharmD^5*, Zangdong He, PhD^5*, David M Kleinman, MD^6*, Debra Schaumberg, OD, MPH, ScD^7*, Angely Loubert, PharmD, MSc^8*, Juliette Meunier, MSc^8*, Antoine Regnault, PhD^8* and Laurie Eliason, MPH^5*

¹University College London Hospitals, NHS Foundation Trust, London, United Kingdom
²Emory University, Winship Cancer Institute, Atlanta, GA
³Levine Cancer Institute, Atrium Health, Charlotte, NC
⁴NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
⁵GlaxoSmithKline, Upper Providence, PA
⁶Flaum Eye Institute, University of Rochester, Rochester, NY
⁷Department of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT
⁸Modus Outcomes, Lyon, France

Evangelos Terpos, MD, PhD¹, Efstathios Kastritis, MD^1*, Evdoxia Hatjiharissi, MD^2*, Eirini Katodritou, MD^3*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Evgenia Verrou, MD^3*, Maria Gavriatopoulou^1*, Alexandros Leonidakis, PhD^4*, Ioannis Ntanasis-Stathopoulos, MD^1*, Sosana Delimpasi, MD^5*, Marie-Christine Kyrtsonis, MD⁶, Maria Papaioannou, MD^2*, Argiris Symeonidis, MD, PhD⁷ and Meletios A Dimopoulos⁸

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²First Department of Internal Medicine, Division of Hematology, AHEPA University Hospital, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece
³Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
⁴Health Data Specialists S.A., Athens, Greece
⁵Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁶First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁷Hematology Division, Department of Internal Medicine, University of Patras, Medical School, Patras, Greece
⁸Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Bharat Nandakumar^1*, Prashant Kapoor, MD², Moritz Binder, MD, MPH¹, Francis K. Buadi, MB, CHB^2*, Martha Q. Lacy, MD², Morie Gertz², Angela Dispenzieri, MD³, David Dingli, MD, PhD², Yi L. Hwa, NP¹, Amie Fonder, PA-C, MS^1*, Miriam A. Hobbs, APRN, CNP, DNP^1*, Suzanne R. Hayman, MD¹, John A. Lust, MD, PhD¹, Stephen J. Russell, MD, PhD¹, Nelson Leung, MD², Ronald S. Go, MD¹, Yi Lin, MD, PhD¹, Wilson I Gonsalves, MD², Taxiarchis Kourelis, MD², Rahma M Warsame, MD³, Mustaqeem A. Siddiqui, MD, MBA¹, Robert A. Kyle, MD², S. Vincent Rajkumar, MD² and Shaji K. Kumar, MD²

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic Rochester, Division of Hematology, Rochester, MN
³Mayo Clinic, Rochester, MN

Diana Basali, MD^1*, Jennifer Tran, DO^2*, Wei Wei, MS^3*, Sherry Fada^4*, Brittany Lewis^4* and Jason Valent, MD⁴

¹Department of Internal Medicine, Cleveland Clinic, Pepper Pike, OH
²Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
³Cleveland Clinic, Cleveland, OH
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Ola Landgren, MD, PhD¹, Katja Weisel, MD^2*, Laura Rosinol, MD, PhD^3*, Philippe Moreau^4*, Mehmet Turgut, MD^5*, Roman Hajek, MD, PhD⁶, Peter Mollee, FRACP, MBBS, MSc, FRCPA⁷, Jin Seok Kim, MD, PhD^8*, Jianqi Zhang^9*, Ning Go, PhD^9*, Christopher L. Morris, PhD, MD^9* and Saad Z. Usmani, MD, MBBS, MBA¹⁰

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Oncology, Hematology and BMT, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
³Servicio de Onco-Hematología, Hospital Clínica de Barcelona, Barcelona, Spain
⁴Department of Hematology, CHU de Nantes, Nantes, France
⁵Department of Internal Medicine, Division of Hematology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey
⁶Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
⁷Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
⁸Yonsei University College of Medicine, Severance Hospital, Seoul, Korea, Republic of (South)
⁹Amgen Inc, Thousand Oaks, CA
¹⁰Atrium Health, Charlotte, NC

Arghya Ray, PhD¹, Yan Song, PhD^2*, Ting DU, PhD^1*, Clifton C. Mo, MD³, Arturo Olguin^4*, Janice Chen, PhD^5*, Christopher Brooks, PhD⁵, Tariq I. Mughal, MD, FRCP^5,6*, Paul G. Richardson, MD^3,7, Dharminder Chauhan, PhD¹ and Kenneth Anderson, MD⁸

¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Dana-Farber Cancer Institute, Harvard Medical School, Brookline, MA
³The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Stemline Therapeutics Inc., New York, NY
⁵Stemline Therapeutics, New York, NY
⁶Tufts University School of Medicine, Boston, MA
⁷Dana-Farber Cancer Institute, Boston, MA
⁸The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Anna Kalff, MBBS¹, Sam Norton, PhD^2*, Tiffany Khong, BSc, PhD³, Malarmathy Ramachandran^4*, Mary H. Young, PhD^5,6*, William Pierceall^7*, Anjan Thakurta^7*, Udo Oppermann, PhD^8*, Manman Guo^9*, John Reynolds, PhD^10* and Andrew Spencer¹¹

¹Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Prahran, VIC, Australia
²Nanix Ltd, Dunedin, New Zealand
³Myeloma Research Group, Alfred Hospital-Monash University, Melbourne, Australia
⁴Myeloma Research Group, Monash University, Melbourne, VIC, AUS
⁵Celgene Corporation, Seattle, WA
⁶Translational Medicine, Bristol-Myers Squibb, Summit, NJ
⁷Bristol Myers Squibb, Princeton, NJ
⁸Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom
⁹Oxford University, Oxford, United Kingdom
¹⁰The Alfred and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
¹¹Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia

Shaji K. Kumar, MD¹, Al-Ola Abdallah, MD², Ashraf Z. Badros, MD³, Betsy Laplant, MS^4*, Binod Dhakal, MS⁵, Melissa Alsina, MD⁶, Rafat Abonour, MD⁷, Cara A. Rosenbaum, MD^8*, William I Bensinger, MD^9*, Manisha Bhutani, MD¹⁰, Andrzej Jakubowiak, MD, PhD¹¹, Erica Kim^12* and Brian G.M. Durie, MD¹³

¹Mayo Clinic Rochester, Division of Hematology, Rochester, MN
²University of Kansas Medical Center, Westwood, KS
³The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD
⁴Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN
⁵Medical College of Wisconsin, Milwaukee, WI
⁶Department of Blood & Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Ctr. Hematologic Malignancies Program, Tampa, FL
⁷Indiana Cancer Pavilion, Indianapolis, IN
⁸Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁹Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
¹⁰Levine L. Cancer Institute, Charlotte, NC
¹¹University of Chicago, Chicago, IL
¹²Trevie Research, Los Angeles
¹³Cedars Sinai Cancer Center, Los Angeles, CA

Grzegorz Charlinski, MD PhD^1*, Agata Tyczyńska, MD^2*, Jan M Zaucha, MD, PhD^3*, Adriana Czyz, MD^4*, Jarosław Czyż, MD PhD^5*, Dominik Dytfeld, MD PhD^6*, Bartosz Malecki, MD^7*, Lidia Gil, MD PhD⁸, Szymon Fornagiel, MD^9*, Sebastian Grosicki, MD, PhD¹⁰, Agnieszka Barchnicka, MD^11*, Jadwiga Holojda, MD^12*, Agnieszka Kolkowska, MD, PhD^13*, Iwona Hus, MD, PhD^13*, Grzegorz Helbig, MD PhD^14,15*, Anna Kopinska, MD^14*, Anna Masternak, MD^16*, Dariusz Woszczyk, MD PhD^17*, Miroslaw Markiewicz, MD PhD^18*, Jaroslaw Piszcz, MD PhD¹⁹, Janusz Kloczko, MD PhD^20*, Lidia Usnarska-Zubkiewicz, MD PhD^21*, Tomasz Wrobel, MD, PhD²¹, Pawel J. Robak, MD PhD^22*, Tadeusz Robak, MD PhD²², Anna Waszczuk-Gajda, MD^23*, Grzegorz Basak, MD, PhD^24* and Artur Jurczyszyn, MD PhD^25*

¹Department of Hematology, Warmian-Masurian Cancer Center Of The Ministry Of The Interior And Administration’s Hospital, Olsztyn, Poland
²Szpital Morski im P.C.K. Gdynia, Gdynia, Poland
³Gumed, Gdansk, POL
⁴Collegium Medicum, Bydgoszcz, Poland, Bydgoszcz, Poland
⁵Department of Hematology, Collegium Medicum, Bydgoszcz, Poland
⁶Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences in Poznan, Poznan, Poland
⁷Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences in Pozn, Poznan, Poland
⁸Poznan University of Medical Sciences, Poznan, Poland
⁹Department of Hematology, Szpital Specjalistyczny, Nowy Sacz, Poland
¹⁰Department of Hematology and Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland
¹¹Samodzielny Publiczny Zakład Opieki Zdrowotnej Zespół Szpitali Miejskich, Chorzow, POL
¹²Department of Hematology, Provintial Specialized Hospital, Legnica, Poland
¹³Institute of Hematology and Transfusion Medicine, Warsaw, Poland
¹⁴Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
¹⁵Silesian Medical University, Katowice, Poland
¹⁶Department of Hematology and Hematooncology, District Specialist Hospital, Opole, Opole, Poland
¹⁷Hematology Department, University of Opole, Opole, Poland
¹⁸Department of Haematology Faculty of Medicine, University of Rzeszow, Rzeszow, Poland
¹⁹Hematology Department, Medical University of Bialystok, Bialystok, Poland
²⁰Department of Hematology, Medical University of Bialystok, Bialystok, Poland
²¹Wrocław Medical University, Wrocław, Poland
²²Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland
²³Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
²⁴Medical University of Warsaw, Warsaw, Poland
²⁵Department of Hematology, Jagiellonian University Medical College, Cracow, Poland

Katja Weisel, MD^1*, George F. Geils, MD², Lionel Karlin, MD^3*, Peter Mollee, FRACP, MBBS, MSc, FRCPA⁴, Tae-Hoon Chung^5*, Chang-Ki Min, MD, PhD^6*, Kazutaka Sunami, MD, PhD⁷, Amanda Goldrick, MD^8*, Belle Fang^8*, Jessica Fowler, PhD^8* and Maria-Victoria Mateos, MD, PhD⁹

¹Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
²Charleston Oncology, Charleston, SC
³Centre Hospitalier Lyon Sud, Lyon, France
⁴Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
⁵National University of Singapore, Singapore, SGP
⁶Seoul St. Mary's Hospital, Seoul, Korea, Republic of (South)
⁷National Hospital Organization Okayama Medical Center, Okayama, Japan
⁸Amgen Inc., Thousand Oaks, CA
⁹Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain

Enrique M. Ocio, MD, PhD¹, Sara Bringhen, MD², Stefania Oliva^3*, Axel Nogai, MD^4*, Philippe Moreau, MD^5*, Joaquin Martinez-Lopez, MD^6*, Paula Rodriguez-Otero, MD, PhD^7*, Nadia Le Roux^8*, Sandrine Macé^9*, Marie-Claude Rouchon^10*, Qiuyan Wang^11* and Maria-Victoria Mateos, MD, PhD¹²

¹University Hospital Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain
²Myeloma Unit, Division of Hematology, University of Torino, Azienda-Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
³Myeloma Unit, Division of Hematology, University of Torino, TORINO, Italy
⁴Division of Hematology and Oncology at Campus Benjamin Franklin (CBF), Charité, Berlin, Germany
⁵Hematology Department, CHU Nantes, Nantes, France
⁶Hematology and hemotherapy department, Hospital Universitario 12 De Octubre, Madrid, Spain
⁷Center for Applied Medical Research (CIMA), IDISNA, University Clinic of Navarra, Pamplona, Spain
⁸Sanofi Oncology Development, Vitry-Sur-Seine, France
⁹Sanofi Research and Development, Vitry-Sur-Seine, France
¹⁰Sanofi Translational Medicine and Early Development, Montpellier, France
¹¹Sanofi, Beijing, China
¹²University Hospital of Salamanca (IBSAL) & Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Meral Beksac, MD¹, Paul G. Richardson, MD², Ali Unal, MD³, Paolo Corradini⁴, Sosana DeLimpasi, MD^5*, Zafer Gulbas, MD^6*, Ian H. Kerridge, FRACP FRCPA MPhil BA^7*, Gabor Mikala, MD, PhD^8*, Annette Neylon, MD, FRCP, FRCPath, FRACP, MBBS^9*, Argiris Symeonidis, MD, PhD¹⁰, Sara Bringhen, MD¹¹, Philippe Moreau^12*, Helgi van de Velde, MD, PhD¹³, Frank Campana, MD^14*, Solenn Le Guennec^15* and Ivan Spicka, MD, PhD^16,17*

¹Ankara University, Department of Hematology, Ankara, Turkey
²The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Department of Hematology, Erciyes University Medical School, Kayseri, Turkey
⁴Division of Hematology, Istituto Nazionale dei Tumori, University of Milano, Milan, Italy
⁵Department of Haematology, General Hospital of Athens, Athens, Greece
⁶Anadolu Medical Center, Kocaeli, Turkey
⁷Department of Haematology, Royal North Shore Hospital, Sydney, Australia
⁸Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, Budapest, Hungary
⁹Department of Haematology, Dunedin Hospital, Dunedin, New Zealand
¹⁰Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece
¹¹Myeloma Unit, Division of Hematology, University of Torino, Azienda-Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
¹²Hematology Department, Nantes University Hospital, Nantes, France
¹³Sanofi R&D, Cambridge, MA
¹⁴Sanofi Genzyme, Cambridge, MA
¹⁵Sanofi R&D, Vitry-Sur-Seine, France
¹⁶1st Internal Clinic - Clinic of Hematology, General University Hospital, Prague, Czech Republic
¹⁷First Faculty of Medicine, Charles University, Prague, Czech Republic

Jin Lu¹, Weijun Fu, MD^2*, Wei Li, MD^3*, Jianda Hu, MD, PhD⁴, Gang An, MD, PhD^5*, Yafei Wang^6*, Chengcheng Fu^7*, Lijuan Chen, MD, PhD^8*, Jie Jin, MD, PhD^9*, Xinan Cen^10*, Zheng Ge, MD, PhD¹¹, Zhen Cai, MD, PhD^9*, Ting Niu, MD, PhD¹², Andrew Spencer, DM¹³, Katja Weisel, MD^14*, María-Victoria Mateos, MD, PhD¹⁵, Ajay Nooka, MD, MPH¹⁶, Ming Qi, MD, PhD¹⁷, Steven Sun^18*, Xue Gai^19*, Weiping Liu^20*, Xue Yang^20* and Xiaojun Huang¹

¹Peking University People’s Hospital, National Clinical Research Center for Hematologic Disease, Collaborative Innovation Center of Hematology, Beijing, China
²Shanghai Changzheng Hospital, Shanghai, China
³The First Hospital of Jilin University, Changchun, Jilin, China
⁴Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou, Fujian, China
⁵Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁶Tianjin Cancer Hospital, Tianjin, China
⁷The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
⁸Jiangsu Province Hospital, Nanjing, Jiangsu, China
⁹The First Affiliated Hospital of Zhejiang University, College of Medicine, Hangzhou, Zhejiang, China
¹⁰Peking University First Hospital, Beijing, China
¹¹Zhongda Hospital Southeast University, Nanjing, Jiangsu, China
¹²West China Hospital Sichuan University, Cheng Du, Sichuan, China
¹³Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia
¹⁴University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
¹⁵University Hospital of Salamanca/IBSAL/Cancer Research Center- IBMCC (USAL-CSIC), Salamanca, Spain
¹⁶Winship Cancer Institute, Emory University, Atlanta, GA
¹⁷Janssen Research & Development, LLC, Spring House, PA
¹⁸Janssen Research & Development, LLC, Raritan, NJ
¹⁹Janssen Research & Development, LLC, Beijing, China
²⁰Janssen Research & Development, LLC, Shanghai, China

Thomas Martin III, MD¹, Yi Lin, MD, PhD², Mounzer Agha, MD³, Adam D. Cohen, MD⁴, Myo Htut, MD⁵, A. Keith Stewart, MBChB^6*, Parameswaran Hari, MBBS, MD⁷, Jesus G. Berdeja, MD⁸, Deepu Madduri, MD^9*, Saad Z. Usmani, MD, MBBS, MBA¹⁰, Tzu-Min Yeh^11*, Alicia J. Allred, PhD^12*, Yunsi Olyslager, MSc^13*, Arnob Banerjee, MD^12*, Jenna D. Goldberg, MD^11*, Jordan M. Schecter, MD¹¹, Carolyn C. Jackson, MD, MPH^11*, William Deraedt, MSc^13*, Katharine S. Gries, PhD, PharmD^14*, John Fastenau, RPh, MPH, PhD^11*, Xiaoling Wu, PhD^15*, Marlene J. Carrasco, MD, PhD, MPH^15*, Muhammad Akram, MD^15*, Farah Hossain, PharmD^15*, Andrzej Jakubowiak, MD, PhD¹⁶ and Sundar Jagannath, MD^17*

¹Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
²Division of Hematology, Mayo Clinic, Rochester, MN
³UPMC Hillman Cancer Center, Pittsburgh, PA
⁴University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA
⁵City of Hope Comprehensive Cancer Center, Duarte, CA
⁶UHN and the Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Brookfield, WI
⁸Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
⁹Mount Sinai Medical Center, New York, NY
¹⁰Levine Cancer Institute, Charlotte, NC
¹¹Janssen R&D, Raritan, NJ
¹²Janssen R&D, Spring House, PA
¹³Janssen R&D, Beerse, Belgium
¹⁴Janssen Global Services, LLC, Raritan, NJ
¹⁵Legend Biotech USA Inc., Piscataway, NJ
¹⁶University of Chicago, Chicago, IL
¹⁷Department of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY

Heinz Ludwig, MD¹, Evangelos Terpos, MD, PhD², María-Victoria Mateos, MD, PhD³, Mario Boccadoro⁴, Bhuvan Kishore^5*, Karthik Ramasamy⁶, Sylvie Fernandez^7*, Fabio Ferri^8*, Nawal Bent-Ennakhil^9*, Athanasios Zomas^9*, François Gavini^9* and Roman Hajek, MD¹⁰

¹Wilhelminen Cancer Research Institute, c/o Department of Medicine I, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Departamento de Hematología, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
⁴Division of Hematology, University of Torino, Torino, Italy
⁵University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
⁶Department of Haematology, Oxford University Hospital, NHS Trust, Oxford, United Kingdom
⁷MediNeos Observational Research, Modena, Italy
⁸Epidemiology and Outcome Research, MediNeos Observational Research, Modena, Italy
⁹Medical Affairs, Europe & Canada, Takeda Pharmaceuticals International AG, Zurich, Switzerland
¹⁰University Hospital Ostrava, Ostrava, Czech Republic

Alessandra Larocca¹, Paul G. Richardson, MD², Albert Oriol^3*, Joan Blade Creixenti⁴, Michele Cavo^5*, Paula Rodríguez-Otero, MD, PhD^6*, Xavier Leleu, MD⁷, Maxim Norkin, MD, PhD^8*, Omar Nadeem, MD^2*, John W. Hiemenz, MD^9*, Hani Hassoun, MD¹⁰, Cyrille Touzeau^11,12,13*, Adrián Alegre Amor, MD, PhD^14*, Agne Paner, MD¹⁵, Christopher Maisel, MD¹⁶, Amitabha Mazumder, MD^17*, Anastasios Raptis, MD¹⁸, Noemí Puig, MD, PhD^19*, Marcus Thuresson, PhD^20*, Johan Harmenberg, MD, PhD²⁰, Bengt Gustavsson, Dr Med Sci, MSc Pharm^20* and María-Victoria Mateos, MD, PhD¹⁹

¹Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy
²Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁴Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain
⁵Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁶Clínica Universidad de Navarra, Pamplona, Spain
⁷CHU de Poitiers, Poitiers, France
⁸Baptist MD Anderson Cancer Center, Jacksonville, FL
⁹Division of Hematology-Oncology, Department of Medicine, University of Florida, Gainesville, FL
¹⁰Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université d'Angers, Université de Nantes, Nantes, France
¹²Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France
¹³Service d'hématologie Clinique, Centre Hospitalier Universitaire, Place Alexis Ricordeau, Nantes, France
¹⁴Hospital Universitario La Princesa and Hospital Universitario Quironsalud, Madrid, Spain
¹⁵Rush University Medical Center, Chicago, IL
¹⁶Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX
¹⁷The Oncology Institute of Hope and Innovation, Glendale, CA
¹⁸Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
¹⁹Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain
²⁰Oncopeptides AB, Stockholm, Sweden

Anda Gershon^1*, Yutong Liu^2*, Spencer James^1*, Mellissa Williamson^1*, Wan-Jen Hong¹ and Khaled Sarsour^1*

¹Genentech, Inc., South San Francisco, CA
²Genesis Research, Hoboken, NJ

Lilly Wong^1*, Manisha Lamba^1*, María Dolores Jiménez Nuñez^2*, Daniel Bauer^1*, Paul G. Richardson, MD³, Nizar Bahlis, MD⁴, Annette J. Vangsted^5*, Karthik Ramasamy⁶, Suzanne Trudel^7*, Joaquín Martínez-Lopez^8*, María-Victoria Mateos⁹, Paula Rodriguez-Otero, MD, PhD^10*, Sagar Lonial, MD¹¹, Rakesh Popat^12*, Albert Oriol^13*, Chatchada Karanes¹⁴, Robert Z. Orlowski, MD, PhD¹⁵, Jesus G. Berdeja, MD¹⁶, Michael Pourdehnad^1* and Daniel W. Pierce^1*

¹Bristol Myers Squibb, Princeton, NJ
²Celgene Research S.L.U., a Bristol-Myers Squibb Company, Seville, Spain
³Dana-Farber Cancer Institute, Boston, MA
⁴Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
⁵Department of Hematology, Rigshospitalet, Copenhagen, Denmark
⁶Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁷Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
⁸Department of Hematology, Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC, Madrid, Spain
⁹University Hospital of Salamanca/IBSAL, Salamanca, Spain
¹⁰Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain
¹¹Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
¹²NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹³Institut de Recerca contra la Leucèmia Josep Carreras and Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁴Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
¹⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
¹⁶Sarah Cannon Research Institute, Nashville, TN

Cathelijne Fokkema, MD^1*, Bronno Van Der Holt, PhD^2*, Mark van Duin, PhD^1*, Ruth Wester, MD^1*, Tom Cupedo, PhD^1*, Philippe Moreau^3*, Jessica Vermeulen, MD, PhD^4*, Annemiek Broyl, MD, PhD^5* and Pieter Sonneveld, MD, PhD¹

¹Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
²HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
³Department of Hematology, University Hospital Hotel-Dieu, Nantes, France
⁴Janssen Research & Development, LLC, Leiden, Netherlands
⁵Erasmus MC Cancer Institute, Rotterdam, Netherlands

Maria Mateos, MD, PhD^1*, Maria Gavriatopoulou^2*, Thierry Facon, MD^3*, Holger W Auner, MD, PhD⁴, Xavier Leleu, MD⁵, Roman Hajek, MD⁶, Meletios A Dimopoulos⁷, Sosana Delimpasi, MD^8*, Maryana Simonova, MD^9*, Ivan Spicka, MD, PhD^10*, Ludek Pour, MD^11*, Irina Kryachok, MD^12*, Halyna Pylypenko, MD^13*, Vadim A Doronin, MD^14*, Ganna Usenko, MD^15*, Reuben Benjamin, FRCPath, MRCP, MBBS, PhD^16*, Tuphan Kanti Dolai, MBBS, MD, DNB, DM^17*, Dinesh Kumar Sinha, MD^18*, Christopher P. Venner, MD¹⁹, Mamta Garg, MD, FRCP, FRCPath^20*, Don A. Stevens, MD²¹, Hang Quach, MD²², Sundar Jagannath, MD^23*, Philippe Moreau^24*, Moshe Levy, MD^25*, Ashraf Z. Badros, MD²⁶, Larry D. Anderson Jr., MD, PhD²⁷, Nizar Bahlis, MD²⁸, Michele Cavo^29*, Yi Chai^30*, Melina Arazy, MD^31*, Jatin Shah, MD³⁰, Sharon Shacham, PhD, MBA^30*, Michael G Kauffman, MD, PhD³⁰, Paul G. Richardson, MD³² and Sebastian Grosicki, MD, PhD³³

¹Hospital Clinico Universitario de Salamanca, Salamanca, Spain
²Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
³Centre Hospitalier Universitaire (CHU) Lille, Service des Maladies du Sang, University of Lille, Lille, France
⁴Imperial College Healthcare NHS Trust, London, United Kingdom
⁵CHU de Poitiers - Hôpital La Milétrie, Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, POITIERS, France
⁶University Hospital Ostrava, Ostrava, Czech Republic
⁷University of Athens School of Medicine, KIFISIA, Greece
⁸Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁹Institute of Blood Pathology & Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, MA, Ukraine
¹⁰Charles University and General Hospital, Prague, Czech Republic
¹¹University Hospital Brno, Brno, Czech Republic
¹²Oncohematology, National Cancer Institute, Kiev, Ukraine
¹³Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy Regional Oncology Centre, Cherkasy, Ukraine
¹⁴Hematology Department, State Budget Healthcare Institution of Moscow, City Clinical Hospital #40 of Moscow Healthcare Department, Moscow, Russian Federation
¹⁵City Clinical Hospital No. 4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine
¹⁶King's College Hospital NHS Foundation Trust, London, United Kingdom
¹⁷Haematology, NRS Medical College and Hospital, Kolkata, India
¹⁸Indira Gandhi Institute of Medical Sciences, Patna, India
¹⁹Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
²⁰University Hospitals Leicester NHS Trust, Leicester, United Kingdom
²¹Norton Cancer Institute - St Matthews Campus, Louisville, KY
²²St. Vincent’s Hospital, Fitzroy, VIC, Australia
²³Icahn School of Medicine at Mount Sinai, New York, NY
²⁴Department of Hematology, University Hospital of Nantes, Nantes, France
²⁵Baylor University Medical Center, Dallas, TX
²⁶University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²⁷UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX
²⁸University of Calgary, Calgary, AB, Canada
²⁹Seràgnoli Institute of Hematology and Medical Oncology, Bologna University School of Medicine, Bologna, Italy
³⁰Karyopharm Therapeutics, Newton, MA
³¹Karyopharm Therapeutics Inc., Newton, MA
³²Dana-Farber Cancer Institute, Boston, MA
³³Silesian Medical University, Katowice, Poland

Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP¹, Xinhua Li^2*, Cindy Lin^2*, Jin Seok Kim, MD, PhD^3*, Hiroshi Handa, MD, PhD⁴ and Brian G.M. Durie, MD⁵

¹National University Cancer Institute of Singapore, Singapore, Singapore
²Singapore Cancer Research Institute, Singapore, Singapore
³Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance hospital, Seoul, Korea, Republic of (South)
⁴Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan
⁵Cedars Sinai Cancer Center, Los Angeles, CA

Paul G. Richardson, MD¹, Ajay Nooka, MD, MPH², Hang Quach, MD, FRACP, FRCPA, MBBS³, Suzanne Trudel, MD^4*, David Routledge^5,6*, Kevin Song, MD⁷, Hareth Nahi, MD^8*, Sofia Paul^9*, Josephine Khan^10*, Maria Brouch^9*, Geraldine Ferron-Brady, PhD^9*, Anne Yeakey, MD^11*, Chris Shelton^9*, Rocio Montes de Oca, PhD^12*, L. Mary Smith^13*, Ellie Im^14*, Christoph M Ahlers^9*, Elaine M Paul^11*, Beata Holkova⁹, Ira Gupta, MD^15*, Brandon E. Kremer, MD, PhD^14* and Paula Rodriguez-Otero, MD, PhD^16*

¹Dana-Farber Cancer Institute, Boston, MA
²Winship Cancer Institute, Emory University, Atlanta, GA
³University of Melbourne, St. Vincent’s Hospital Melbourne, Melbourne, Australia
⁴Princess Margaret Cancer Center, Toronto, ON, Canada
⁵Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
⁶Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia
⁷The Vancouver General Hospital, Vancouver, BC, CAN
⁸Karolinska University Hospital, Stockholm, Sweden
⁹GlaxoSmithKline, Upper Providence, PA
¹⁰GlaxoSmithKline, Stevenage, United Kingdom
¹¹GlaxoSmithKline, Research Triangle Park, NC
¹²Experimental Medicine Unit Oncology, GlaxoSmithKline, Philadelphia, PA
¹³SpringWorks Therapeutics Inc., Stamford, CT
¹⁴GlaxoSmithKline, Waltham, MA
¹⁵Clinical Oncology, GlaxoSmithKline, Upper Providence, PA
¹⁶Clínica Universidad de Navarra-Pamplona, Navarra, Spain

Gena Kanas^1*, Otavio Clark^1*, Katie Keeven^1*, Knar Nersesyan^1*, Leah Sansbury, PhD^2* and Cosmina Hoggea^2*

¹Kantar, Health Division, New York, NY
²Value Evidence and Outcomes, GlaxoSmithKline, Philadelphia, PA

William Casey Wilson, PhD¹, John Richards, PhD^1*, Robyn J Puro, PhD^1*, Gabriela Andrejeva, PhD^1*, Ben J Capoccia, PhD^1*, Mike J Donio^1*, Ronald R Hiebsch, BS^1*, Prabir Chakraborty, PhD^1*, Victoria Sung, PhD^2* and Daniel S Pereira, PhD¹

¹Arch Oncology, St. Louis, MO
²Arch Oncology, San Francisco, CA

Suzanne Trudel, MD^1*, Randy Davis, PhD^2*, Nicole M. Lewis, MSc^3*, Kalpana K. Bakshi, MSc^3*, Bikramjit Chopra, PhD^4*, Rocio Montes de Oca, PhD^5*, Geraldine Ferron-Brady, PhD^6*, Laurie Eliason, MPH^7*, Brandon E. Kremer, MD, PhD^8*, Ira Gupta, MD^3* and Frank S. Wu, MD PhD³

¹Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada
²Biostatistics, GlaxoSmithKline, Research Triangle Park, NC
³Clinical Oncology, GlaxoSmithKline, Upper Providence, PA
⁴Pharmacovigilance, GlaxoSmithKline, London, United Kingdom
⁵Experimental Medicine Unit Oncology, GlaxoSmithKline, Philadelphia, PA
⁶Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline, Upper Providence, PA
⁷Value Evidence and Outcomes, GlaxoSmithKline, Upper Providence, PA
⁸Clinical Development, GlaxoSmithKline, Upper Providence, PA

Peter Mollee, FRACP, MBBS, MSc, FRCPA^1,2, John Reynolds, PhD^3*, Wojt Janowski, FRCPA, FRACP⁴, Hang Quach, MD, FRACP, FRCPA, MBBS⁵, Philip Campbell, MBBS⁶, Simon D. Gibbs, FRACP, FRCPA, MBBS^7*, Sophie Lee, FRACP, FRCPA, PhD^8*, James D'Rozario, MBBS, FRACP, FRCPA⁹, Kerry Taylor, FRACP, FRCPA, MBBS^10*, Tara Cochrane, MBBS, FRCPA, FRACP¹¹, Craig Thomas Wallington-Beddoe, BSc, MBBS, PhD, FRACP, FRCPA^12*, Fiona Kwok, FRACP, FRCPA, MBBS^13*, Nicholas Weber, MBBS^14*, Ian H. Kerridge, FRACP FRCPA MPhil BA^15*, Helen Weston, MBBS, FRACP, FRCPA^16*, Phoebe Joy Ho, MBBS, DPhil, FRACP, FRCPA¹⁷, Noemi Horvath, MB ChB FRACP FRCPA¹⁸, Flora Yuen, BBiomedSc^19* and Andrew Spencer²⁰

¹Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
²University of Queensland, Brisbane, QLD, Australia
³Biostatistics Consulting Platform, Alfred Health and Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia
⁴Calvary Mater Newcastle, Waratah, AUS
⁵Melbourne Blood Specialist, East Melbourne, VIC, Australia
⁶University Hospital Geelong, Geelong, Australia
⁷The Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash University Easter Health Clinical School, Melbourne, VIC, Australia
⁸Department of Haematology and Medical Oncology, Western Health, St Albans, Australia
⁹The Canberra Hospital, Canberra, Australia
¹⁰ICON Cancer Care, South Brisbane, AUS
¹¹Department of Hematology, Gold Coast University Hospital, Southport, Australia
¹²Flinders Medical Centre Flinders University, Adelaide, Australia
¹³Clinical Haematology, Westmead Hospital, Sydney, NSW, Australia
¹⁴Royal Brisbane and Women's Hospital, Brisbane, AUS
¹⁵Department of Haematology, Royal North Shore Hospital, Sydney, Australia
¹⁶Haematology Department, Sunshine Coast University Hospital, Sunshione Coast, Australia
¹⁷Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
¹⁸Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia
¹⁹Department of Clinical Haematology, Alfred Hospital, Melbourne, Australia
²⁰Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia

Baiyan Wang, MD, PhD^1*, Jie Liu, MD^1*, Wan-Hong Zhao, MD, PhD^1*, Yin-Xia Chen, MD^1*, Xing-Mei Cao, MD^1*, Yun Yang, MD^1*, Yi-Lin Zhang, MD^1*, Fang-Xia Wang, MD, PhD^1*, Peng-Yu Zhang, MD, PhD^1*, Bo Lei, MD^1*, Liu-Fang Gu, MD, PhD^1*, Jian-Li Wang, MD, PhD^1*, Frank Xiao-Hu Fan, MD, PhD^2*, Wang-Gang Zhang, MD, PhD^1* and Ai-Li He, MD, PhD^3*

¹Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
²Nanjing Legend Biotech, Nanjing, China
³Department of Hematology and National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

Ashutosh D. Wechalekar, MD^1*, Giovanni Palladini, MD, PhD², Giampaolo Merlini, MD^3*, Raymond L. Comenzo, MD⁴, Arnaud Jaccard, MD, PhD^5*, NamPhuong Tran, MD^6*, Huiling Pei, PhD^7*, Sandra Y. Vasey, MSc^8*, Brenda Tromp, MSc⁹, Brendan M. Weiss, MD^8*, Jessica Vermeulen, MD, PhD¹⁰ and Efstathios Kastritis, MD^11*

¹University College London, London, United Kingdom
²Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, PV, Italy
³Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
⁴Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
⁵Centre Hospitalier Universitaire and Reference Center for AL Amyloidosis, Limoges, France
⁶Janssen Research & Development, LLC, Los Angeles, CA
⁷Janssen Research & Development, LLC, Titusville, NJ
⁸Janssen Research & Development, LLC, Spring House, PA
⁹Janssen Research & Development, LLC, Leiden, Netherlands
¹⁰Janssen Research & Development, LLC, Leiden, CB, Netherlands
¹¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, ATHENS, Greece

Joselle Cook, MBBS¹, Kah-Whye Peng, PhD^2*, Brenda F Ginos, B.A.^3*, Amylou C. Dueck, PhD⁴, Marissa Giers, BSN, RN^5*, Nandakumar Packiriswamy, PhD, DVM^6*, Beth Brunton, Ph.D^5*, Mrinal M. Patnaik, MD, MBBS¹, Thomas E. Witzig, MD¹, Francis K. Buadi, MB, CHB^7*, Angela Dispenzieri, MD⁵, Morie A Gertz, MD¹, Ronald S. Go, MD^1,8, Suzanne R. Hayman, MD¹, John A. Lust, MD, PhD¹, David Dingli, MD, PhD⁷, S. Vincent Rajkumar, MD⁷, Nelson Leung, MD¹, Rahma M Warsame, MD¹, Wilson I Gonsalves, MD¹, Taxiarchis Kourelis, MD⁷, Eli Muchtar, MD⁵, P. Leif Bergsagel, MD⁹, Stephen Broski, MD^10*, Prashant Kapoor, MD⁷, Robert A. Kyle, MD⁷, Mustaqeem A. Siddiqui, MD, MBA¹, Amie Fonder, PA-C, MS^1*, Miriam A. Hobbs, APRN, CNP, DNP^1*, Yi L. Hwa, NP¹, Yi Lin, MD, PhD¹¹, Shaji K. Kumar, MD⁷, Stephen J. Russell, MD, PhD² and Martha Q. Lacy, MD⁷

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Molecular Medicine, Mayo Clinic, Rochester, MN
³Department of Health Sciences Research, Mayo Clinic Health System, Scottsdale, AZ
⁴Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
⁵Mayo Clinic, Rochester, MN
⁶Mayo clinic, Rochester, MN
⁷Mayo Clinic Rochester, Division of Hematology, Rochester, MN
⁸Mayo Clinic Rochester, Division of Hematology, Onalaska, WI
⁹Division of Hematology, Mayo Clinic, Scottsdale, AZ
¹⁰Radiology, Mayo Clinic, Rochester, MN
¹¹Mayo Clinic, Division of Hematology, Rochester, MN

Urvi A Shah, MD¹, Kelly Werner, RN^1*, Elizabet Tavitian, BS^1*, Sean Devlin, PhD^2*, Sham Mailankody, MBBS³, Neha Korde, MD¹, Malin Hultcrantz, MD, PhD¹, Carlyn Tan, MD¹, Sydney X. Lu, MD, PhD¹, Eric L Smith, MD, PhD⁴, Francesco Maura, MD¹, Dhwani Patel, MD^1*, Gunjan L. Shah, MD MS⁵, Oscar B Lahoud, MD⁶, Michael Scordo, MD⁷, Richard J Lin, MD, PhD⁸, Parastoo B. Dahi, MD⁹, Heather J Landau, MD¹⁰, David J. Chung, MD, PhD⁶, Hani Hassoun, MD¹, Jonathan Landa, MD^11*, Bernard O'Malley^11*, Christopher Barker, MD^12*, Taha Merghoub, PhD^13*, Sergio A. Giralt, MD¹⁴, Ola Landgren, MD, PhD¹, Joachim Yahalom, MD¹⁵ and Alexander M. Lesokhin, MD¹

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Dana Farber Cancer Institute, Boston
⁵Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
⁸Memorial Sloan Kettering Cancer Center, New York, NY
⁹Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY
¹⁰Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, Scarsdale, NY
¹¹Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Memorial Sloan-Kettering Cancer Ctr., New York, NY
¹⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
¹⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Paolo Milani, MD, PhD¹, Vaishali Sanchorawala, MD², Ramon Lecumberri, MD, PhD^3*, Sunil Saith, MD^4*, Mathew S. Maurer, MD^5*, M. Teresa Cibeira, MD, PhD^6*, Giampaolo Merlini, MD⁷, Stefan Schönland, MD^8* and Giovanni Palladini, MD, PhD⁹

¹Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
²Section of Hematology and Oncology, Boston Medical Center and Boston University School of Medicine, Boston, MA
³Hematology Service, University Clinic of Navarra, Pamplona, Spain
⁴Columbia University, New York
⁵Division of Cardiology, Columbia University, New York, NY
⁶Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic, Barcelona, Spain
⁷Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
⁸Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany
⁹Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, PV, Italy

Barry Paul, MD, MS¹, Myra Robinson, MSPH^2*, Kristen Cassetta^2*, Daniel Slaughter^2*, Jordan Robinson^1*, Ami P Ndiaye, NP^1*, Manisha Bhutani, MD¹, Peter M. Voorhees, MD¹, Saad Z. Usmani, MD, MBBS, MBA¹ and Shebli Atrash, MD¹

¹Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC

Tarek H Mouhieddine, MD¹, Julia Hieulle^2*, Erin Moshier, MS^3*, Josh R. Richter, MD⁴, Hearn Jay Cho, MD, PhD⁴, Samir S. Parekh, MD⁴, Ajai Chari, MD⁴, Bart Barlogie, MD, PhD⁴, Sundar Jagannath, MD⁴ and Deepu Madduri, MD⁴

¹Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
²Service des Maladies du Sang, Centre Hospitalier Régional Universitaire De Lille, Lille, France
³Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Estefania Garcia-Guerrero^1,2*, Luis Gerardo Rodríguez-Lobato^3*, Sophia Danhof, MD^4*, Belén Sierro-Martínez^5*, Ralph Goetz^6*, Markus Sauer^7*, Jose A. Perez-Simon, MD, PhD¹, Hermann Einsele, MD⁴, Michael Hudecek, MD^8* and Sabrina Prommersbe^9*

¹Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain
²Universitätsklinikum Würzburg, Seville, Spain
³Hospital Clinic of Barcelona, Barcelona, Alabama, ESP
⁴Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Wuerzburg, Germany
⁵Institute of Biomedicine of Seville/Virgen del Rocio Hospital, Sevilla, Spain
⁶4Department of Biotechnology and Biophysics, Biocenter, University of Würzburg, Würzburg, Germany
⁷Biotechnology & Biophysics Biocenter, Universitäts Würzburg, Würzburg, Germany
⁸Universitaetsklinikum Wuerzburg, Wuerzburg, BA, Germany
⁹Würzburg University, Wuerzburg, Germany

Abdullah S. Al Saleh, MBBS¹, Alissa Visram, MD¹, Harsh Parmar, MD¹, Angela Dispenzieri, MD², Eli Muchtar, MD^1*, Francis K. Buadi, MB, CHB^1*, Rahma M Warsame, MD², Martha Q. Lacy, MD¹, David Dingli, MD, PhD¹, Nelson Leung, MD¹, Wilson I Gonsalves, MD¹, Prashant Kapoor, MD¹, Taxiarchis Kourelis, MD¹, Morie Gertz¹, Ronald S. Go, MD³, Robert A. Kyle, MD¹, S. Vincent Rajkumar, MD¹ and Shaji K. Kumar, MD¹

¹Mayo Clinic Rochester, Division of Hematology, Rochester, MN
²Mayo Clinic, Rochester, MN
³Mayo Clinic Rochester, Division of Hematology, Onalaska, WI

Abdul Rafae, MD^1*, Ali Jaan, MD^2*, Zahoor Ahmed, MD^3*, Karun Neupane, MBBS, MD^4*, Sara Ashraf, MD^5*, Sundas Ali^6*, Sana Irfan Khan, MD^7*, Israr Khan^8*, Atif Irfan Khan, MD^7*, Ahsan Wahab, MD^9*, Rabia Ali, MBBS^6*, Sara Saeed, MBBS^10*, Mustafa Nadeem Malik, MD^11* and Faiz Anwer, MD¹²

¹Internal Medicine, McLaren Flint-Michigan State University, Flint, MI
²King Edward Medical University, Lahore, Pakistan
³Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
⁴Manipal College of Medical Sciences, Pokhara, Nepal
⁵Sharif Medical and Dental College, Lahore, Pakistan
⁶Rawalpindi Medical University, Rawalpindi, Pakistan
⁷All India Institute Of Medical Sciences, Delhi, India
⁸Bolan Medical College, McDonough, GA
⁹Baptist Medical Center South, Montgomery, AL
¹⁰Wah Medical College, Wah, Pakistan
¹¹Internal Medicine, University of Arizona, Tucson, AZ
¹²Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH

David S. Siegel, MD¹, Gary J. Schiller, MD², Christy J. Samaras, DO³, Michael Sebag, MD, PhD⁴, Jesus G. Berdeja, MD⁵, Siddhartha Ganguly, MD^6*, Jeffrey V. Matous, MD⁷, Kevin W Song, MD, FRCPC⁸, Christopher S. Seet, MD, PhD², Mirelis Acosta-Rivera^9*, Michael Bar^10*, Donald P. Quick, MD¹¹, Bertrand M. Anz III, MD^12*, Gustavo A. Fonseca, MD¹³, Donna E. Reece, MD¹⁴, Kim Lee^15*, Weiyuan Chung^15*, Amit Agarwal, MD, PhD¹⁵ and Nizar Bahlis, MD¹⁶

¹Hackensack Univ. Med. Ctr., Hackensack, NJ
²David Geffen School of Medicine at University of California, Los Angeles, CA
³Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁴Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
⁵Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
⁶The University of Kansas Cancer Center, Fairway, KS
⁷Colorado Blood Cancer Institute, Denver, CO
⁸Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada
⁹Fundación de Investigación, San Juan, Puerto Rico
¹⁰Stamford Hospital, Stamford, CT
¹¹Joe Arrington Cancer Research and Treatment Center, Lubbock, TX
¹²Tennessee Oncology, Chattanooga, TN
¹³Florida Cancer Specialists, St Petersburg, FL
¹⁴Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁵Bristol Myers Squibb, Princeton, NJ
¹⁶Tom Baker Cancer Center, Calgary, AB, Canada

Nathan Martin, PhD^1*, Ethan G. Thompson, PhD^1*, Will Brown, MS^1*, Olivia Finney, PhD^2*, Julie Rytlewski, PhD^1*, Yue Jiang, PhD^1*, Dipen Sangurdekar, PhD^2*, Julie Wang, PharmD, PhD^1*, Hans Bitter, PhD^2*, Ronald J. Hause Jr., PhD^1*, Timothy B. Campbell, MD, PhD^1*, Kristen Hege, MD¹ and Shari Kaiser, PhD^1*

¹Bristol Myers Squibb, Princeton, NJ
²bluebird bio, Cambridge, MA

Philippe Moreau^1*, Meletios A. Dimopoulos, MD², Joseph Mikhael, MD, FRCPC, MEd³, Kwee Yong, MD, PhD^4*, Marcelo Capra, MD, PhD⁵, Thierry Facon, MD^6*, Roman Hajek, MD⁷, Ivan Spicka, MD, PhD^8*, Marie-Laure Risse^9*, Gaelle Asset^10*, Sandrine Macé^11* and Thomas G. Martin III, MD¹²

¹Department of Hematology, University Hospital of Nantes, Nantes, France
²The National and Kapodistrian University of Athens, Athens, Greece
³Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ
⁴University College Hospital, London, United Kingdom
⁵Departamento de Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil
⁶Department of Hematology, Lille University Hospital, Lille, France
⁷Department of Hemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic
⁸First Faculty of Medicine, Charles University, Prague, Czech Republic
⁹Aixial (for Sanofi), Boulogne-Billancourt, France
¹⁰Sanofi R&D, Chilly-Mazarin, France
¹¹Sanofi Research and Development, Vitry-Sur-Seine, France
¹²Department of Hematology, University of California, San Francisco, San Francisco, CA

Jesus F. San-Miguel, MD, PhD¹, Herve Avet-Loiseau^2*, Bruno Paiva, PhD^3*, Shaji K. Kumar, MD⁴, Meletios A. Dimopoulos, MD⁵, Thierry Facon, MD^6*, Maria-Victoria Mateos, MD, PhD⁷, Cyrille Touzeau^8*, Andrzej Jakubowiak, MD, PhD⁹, Saad Z. Usmani, MD, MBBS, MBA¹⁰, Gordon Cook, MD^11*, Michele Cavo^12*, Hang Quach, MD, FRACP, FRCPA, MBBS¹³, Jon Ukropec, PhD¹⁴, Priya Ramaswami^15*, Huiling Pei, PhD^15*, Steven Sun^16*, Jianping Wang^16*, Maria Krevvata, PhD^17*, Nikki DeAngelis^17*, Christoph Heuck^17*, Rian Van Rampelbergh^18*, Anupa Kudva, MD^16*, Rachel Kobos, MD¹⁶, Ming Qi, MD, PhD¹⁷ and Nizar Bahlis, MD¹⁹

¹Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona, Spain
²Unite de Genomique du Myelome, IUC-Oncopole, Toulouse, France
³Clinica Universidad de Navarra, Pamplona, Spain
⁴Department of Hematology, Mayo Clinic Rochester, Rochester, MN
⁵National and Kapodistrian University of Athens, Athens, Greece
⁶CHU Lille, Service des Maladies du Sang F-59000, Lille, France
⁷University Hospital of Salamanca/IBSAL/Cancer Research Center- IBMCC (USAL-CSIC), Salamanca, Spain
⁸Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France
⁹University of Chicago Medical Center, Chicago, IL
¹⁰Levine Cancer Institute, Charlotte, NC
¹¹Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹²Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
¹³University of Melbourne, St. Vincent’s Hospital, Melbourne, Australia
¹⁴Janssen Global Medical Affairs, Horsham, PA
¹⁵Janssen Research & Development, LLC, Titusville, NJ
¹⁶Janssen Research and Development, Raritan, NJ
¹⁷Janssen Research & Development, LLC, Spring House, PA
¹⁸Janssen Research & Development, Beerse, Belgium
¹⁹Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada

Bruno Paiva, PhD^1*, Irene Manrique, PhD^1*, Nicola Giuliani^2,3, Michele Cavo^4*, Christine Rojas, MD^5*, Weijun Fu, MD, PhD^6*, María-Victoria Mateos, MD, PhD⁷, Meletios A Dimopoulos⁸, Alexander Vorog, MD^9*, Cong Li, PhD^9*, Bingxia Wang, PhD^10*, Richard J Labotka, MD⁹ and Ajeeta B Dash, PhD^9*

¹Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Clinica Universidad de Navarra, Pamplona, Spain
²Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
³Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
⁴Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁵Clínica Bupa Reñaca, Universidad de Valparaíso, Universidad de Chile, Chile, Spain
⁶Shanghai Changzheng Hospital, Shanghai, China
⁷University Hospital of Salamanca, CIC, IBMCC, Salamanca, Spain
⁸Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁹Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
¹⁰Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA

Maria Mateos, MD, PhD^1*, Philippe Moreau^2*, Meletios-Athanasios Dimopoulos³, Wan-Jen Hong, MD⁴, Scott Cooper^5*, Yao Yu^6*, Muhammad Jalaluddin, PhD^6*, Jeremy A. Ross^6*, Sudeep Karve^6*, Sheryl Coppola^6*, Paulo C. Maciag^6*, Orlando F. Bueno⁶, Emma Arriola^5* and Shaji K. Kumar, MD⁷

¹Hospital Clinico Universitario de Salamanca, Salamanca, Spain
²Department of Hematology, University Hospital of Nantes, Nantes, France
³The National and Kapodistrian University of Athens, Athens, Greece
⁴Genentech, Inc., South San Francisco, CA
⁵AbbVie, Maidenhead, United Kingdom
⁶AbbVie, Inc., North Chicago, IL
⁷Division of Hematology, Mayo Clinic, Rochester, MN

Despina Fotiou, BMBS, MA^1*, Maria Gavriatopoulou^1*, Ioannis Ntanasis-Stathopoulos, MD^1*, Magdalini Migkou^2*, Nikolaos Kanellias, MD^1*, Panagiotis Malandrakis, MD^1*, Foteini Theodorakakou, MD^1*, Ioanna Dialoupi, MD^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Maria Roussou, MD^1*, Evangelos Terpos, MD, PhD¹, Meletios A. Dimopoulos, MD¹ and Efstathios Kastritis^1*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²National and Kapodistrian University of Athens, Athens, Greece

Paula Rodríguez-Otero, MD, PhD^1*, María-Victoria Mateos, MD, PhD², Albert Oriol^3*, Alessandra Larocca⁴, Joan Blade Creixenti⁵, Michele Cavo^6*, Xavier Leleu, MD⁷, Maxim Norkin, MD, PhD^8*, Omar Nadeem, MD^9*, John W. Hiemenz, MD^10*, Hani Hassoun, MD¹¹, Cyrille Touzeau^12,13,14*, Adrián Alegre Amor, MD, PhD^15*, Agne Paner, MD¹⁶, Christopher Maisel, MD¹⁷, Amitabha Mazumder, MD^18*, Anastasios Raptis, MD¹⁹, Noemí Puig, MD, PhD^2*, Marcus Thuresson, PhD^20*, Johan Harmenberg, MD, PhD²⁰, Olof Harlin, VMD, PhD^20* and Paul G. Richardson, MD⁹

¹Clínica Universidad de Navarra, Pamplona, Spain
²Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain
³Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁴Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy
⁵Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain
⁶Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁷CHU de Poitiers, Poitiers, France
⁸Baptist MD Anderson Cancer Center, Jacksonville, FL
⁹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁰Division of Hematology-Oncology, Department of Medicine, University of Florida, Gainesville, FL
¹¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université d'Angers, Université de Nantes, Nantes, France
¹³Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France
¹⁴Service d'hématologie Clinique, Centre Hospitalier Universitaire, Place Alexis Ricordeau, Nantes, France
¹⁵Hospital Universitario La Princesa and Hospital Universitario Quironsalud, Madrid, Spain
¹⁶Rush University Medical Center, Chicago, IL
¹⁷Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX
¹⁸The Oncology Institute of Hope and Innovation, Glendale, CA
¹⁹Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
²⁰Oncopeptides AB, Stockholm, Sweden

Frances Blevins, PA-C^1*, David Hughes, PharmD^1,2*, Charles Milrod, MD^3*, Preya Patel, MD^4*, Shayna DeMari, BA^5*, Adam Lerner, MD¹, Shayna Sarosiek, MD¹, Vaishali Sanchorawala, MD^6,7 and John Mark Sloan, MD¹

¹Section of Hematology & Medical Oncology, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA
²Department of Pharmacy, Boston Medical Center, Boston, MA
³Boston University School of Medicine, Boston, MA
⁴Boston University, Boston, MA
⁵Albany College of Pharmacy and Health Sciences, Albany, NY
⁶Boston Medical Center Corporation, Boston, MA
⁷Amyloidosis Center, Boston University School of Medicine, Boston, MA

Michel Delforge, MD PhD¹, Rachid C. Baz, MD², Michele Cavo^3*, Natalie S. Callander, MD⁴, Armin Ghobadi, MD⁵, Paula Rodriguez-Otero, MD, PhD^6*, María-Victoria Mateos, MD, PhD^7*, Monica Massaro, MPH^8*, Li Ding^9*, Payal Patel^9*, Gianfranco Pittari, MD, PhD^10*, Steven Novick, MD, PhD^9*, Sergio A. Giralt, MD¹¹ and Jesus G. Berdeja, MD¹²

¹Department of Hematology, University Hospital Leuven, Leuven, Belgium
²H. Lee Moffitt Cancer Center, Tampa, FL
³Bologna University School of Medicine, Bologna, Italy
⁴University of Wisconsin Hospital and Clinics, Madison, WI
⁵Washington University School of Medicine, St Louis, MO
⁶University of Navarra, Pamplona, Spain
⁷Hospital Clinico Universitario de Salamanca, Salamanca, Spain
⁸bluebird bio, Cambridge, MA
⁹Bristol Myers Squibb, Princeton, NJ
¹⁰Celgene International Sàrl, a Bristol Myers Squibb Company, Boudry, NJ, Switzerland
¹¹Memorial Sloan Kettering Cancer Center, New York, NY
¹²Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN

Efstathios Kastritis, MD^1*, Pantelis Roussakis, MSc^2*, Ioannis V Kostopoulos, PhD^2*, Foteini Theodorakakou, MD^3*, Despina Fotiou, BMBS, MA^3*, Nikolaos Kanellias, MD^3*, Ioanna Dialoupi, MD^3*, Magdalini Migkou^4*, Maria Roussou, MD^3*, Evangelos Eleutherakis-Papaiakovou, MD^3*, Asimina Papanikolaou, MD^5*, Anastasia Gatou, MD^6*, Ourania E. Tsitsilonis, MD, PhD^2*, Maria Gavriatopoulou^3*, Evangelos Terpos, MD, PhD³ and Meletios A Dimopoulos⁷

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, ATHENS, Greece
²Department of Biology, National and Kapodistrian University of Athens, Athens, Greece
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴National and Kapodistrian University of Athens, Athens, Greece
⁵Department of Hemopathology, "Evangelismos" General Hospital, Athens, Greece
⁶Blood Bank, Alexandra General Hospital, Athens, Greece
⁷Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Meletios A Dimopoulos¹, Hang Quach, MD, FRACP, FRCPA, MBBS², María-Victoria Mateos³, Ola Landgren, MD, PhD⁴, Xavier Leleu, MD⁵, David S. Siegel, MD⁶, Katja Weisel, MD^7*, Maria Gavriatopoulou^8*, Albert Oriol, MD^9*, Neil K Rabin^10*, Ajay Nooka, MD, MPH¹¹, Ming Qi, MD, PhD^12*, Bifeng Ding^13*, Anita Zahlten-Kumeli¹⁴ and Saad Z. Usmani, MD, MBBS, MBA^15,16

¹University of Athens School of Medicine, Athens, Greece
²Melbourne Blood Specialist, East Melbourne, VIC, Australia
³Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain
⁴Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵CHU de Poitiers - Hôpital La Milétrie, Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, POITIERS, France
⁶Hackensack Univ. Med. Ctr., Hackensack, NJ
⁷Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁸Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁹Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁰University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹¹Winship Cancer Institute, Emory University, Atlanta, GA
¹²Janssen Research & Development, Spring House, PA
¹³Amgen Inc., 1 Amgen Center Drive, CA
¹⁴Amgen Inc., Thousand Oaks, CA
¹⁵Levine Cancer Institute, Charlotte, NC
¹⁶Atrium Health, Charlotte, NC

Swetha Kambhampati, MD¹, Sandy W. Wong, MD², Thomas Martin III, MD³, Jeffrey L. Wolf, MD³, Priya Choudhry, PhD^4*, William Karlon, MD, PhD^5*, Arun P. Wiita, MD, PhD⁶ and Nina Shah, MD⁷

¹Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA
²Tufts Medical Center, San Francisco, CA
³University of California, San Francisco, San Francisco, CA
⁴Genentech, San Francisco
⁵University of California San Francisco, San Francisco
⁶UCSF, San Francisco, CA
⁷Associate Professor of Medicine, University of California San Francisco, San Francisco, CA

Elisavet Vlachonikola, PhD^1,2*, Efstathios Kastritis, MD^3*, Evdoxia Hatjiharissi, MD^4*, Eirini Katodritou, MD^5*, Alexandra Siorenta, MD^6*, Electra Sofou^1*, Marina Gerousi^1,7*, Konstantia Kotta^1*, Maria Karipidou^1*, Maria Gavriatopoulou^8*, Sosana Delimpasi, MD^9*, Argiris Symeonidis, MD, PhD¹⁰, Kostas Stamatopoulos, MD^1,11, Meletios A Dimopoulos⁸, Evangelos Terpos, MD, PhD⁸ and Anastasia Chatzidimitriou^1,11*

¹Institute of Applied Biosciences (INAB), Centre for Research and Technology Hellas (CERTH), Thessaloniki, Greece
²Department of Genetics, Development and Molecular Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, ATHENS, Greece
⁴First Department of Internal Medicine, Division of Hematology, AHEPA University Hospital, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece
⁵Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
⁶Immunology Department, G. Gennimatas Hospital, Athens, Greece
⁷Medical Department, Democritus University of Thrace, Alexandroupolis, Greece
⁸Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁹Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
¹⁰Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece
¹¹Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Ricardo Parrondo, MD¹, Muhamad Alhaj Moustafa, MD², Craig B. Reeder, MD³, Taimur Sher, MD², Vivek Roy, MD⁴, Rahma M Warsame, MD⁵, Victoria R. Alegria^6*, Wilson I Gonsalves, MD⁷, Prashant Kapoor, MD⁵, David Dingli, MD, PhD⁸, Suzanne R. Hayman, MD⁷, Asher Chanan-Khan, MBBS, MD⁹ and Sikander Ailawadhi, MD²

¹Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL
²Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
³Mayo Clinic, Scottsdale, AZ
⁴Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
⁵Mayo Clinic, Rochester, MN
⁶Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸Mayo Clinic Rochester, Division of Hematology, Rochester, MN
⁹Division of Hematology and Medical Oncology, Professor of Medicine, Mayo Clinic, Jacksonville, FL